These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29651548)

  • 1. [Diagnosis of dry eye disease].
    Jacobi C; Messmer EM
    Ophthalmologe; 2018 May; 115(5):433-450. PubMed ID: 29651548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions.
    Shimazaki J
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES7-DES12. PubMed ID: 30481800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is Important in Diagnosing Dry Eye Disease - Recommendations According to current Guidelines (DEWS II, DOG/BVA)].
    Jacobi C
    Klin Monbl Augenheilkd; 2022 Oct; 239(10):1273-1286. PubMed ID: 35970193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear film assessments for the diagnosis of dry eye.
    Dohlman TH; Ciralsky JB; Lai EC
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):487-91. PubMed ID: 27585060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.
    Harrell CR; Feulner L; Djonov V; Pavlovic D; Volarevic V
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFOS DEWS II Definition and Classification Report.
    Craig JP; Nichols KK; Akpek EK; Caffery B; Dua HS; Joo CK; Liu Z; Nelson JD; Nichols JJ; Tsubota K; Stapleton F
    Ocul Surf; 2017 Jul; 15(3):276-283. PubMed ID: 28736335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting.
    Baudouin C; Aragona P; Messmer EM; Tomlinson A; Calonge M; Boboridis KG; Akova YA; Geerling G; Labetoulle M; Rolando M
    Ocul Surf; 2013 Oct; 11(4):246-58. PubMed ID: 24112228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Dry Eye from a Clinical Perspective.
    Tsubota K; Pflugfelder SC; Liu Z; Baudouin C; Kim HM; Messmer EM; Kruse F; Liang L; Carreno-Galeano JT; Rolando M; Yokoi N; Kinoshita S; Dana R
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFOS DEWS II Diagnostic Methodology report.
    Wolffsohn JS; Arita R; Chalmers R; Djalilian A; Dogru M; Dumbleton K; Gupta PK; Karpecki P; Lazreg S; Pult H; Sullivan BD; Tomlinson A; Tong L; Villani E; Yoon KC; Jones L; Craig JP
    Ocul Surf; 2017 Jul; 15(3):539-574. PubMed ID: 28736342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current methods of tear film stability assessment].
    Safonova TN; Sikach EI; Ozheredov IA
    Vestn Oftalmol; 2019; 135(5):92-98. PubMed ID: 31714519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset.
    Guzmán M; Miglio M; Keitelman I; Shiromizu CM; Sabbione F; Fuentes F; Trevani AS; Giordano MN; Galletti JG
    Immunology; 2020 Oct; 161(2):148-161. PubMed ID: 32702135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRY EYE DISEASE. A REVIEW.
    Zemanová M
    Cesk Slov Oftalmol; 2021; 77(3):107–119. PubMed ID: 34107689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of dry eye.
    Bron AJ
    Surv Ophthalmol; 2001 Mar; 45 Suppl 2():S221-6. PubMed ID: 11587146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel current and future therapy options for treatment of dry eye disease].
    Messmer EM
    Ophthalmologe; 2018 Feb; 115(2):100-106. PubMed ID: 29134276
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.